Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Francuski

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Patient-Reported Outcomes|July 1, 2025
Qualitative exploration of women's experiences of vasomotor symptoms to support the content validity of patient-reported outcomesClaudia Haberland, Melissa Barclay, Sophie Whyman, et al.
Journal of Pediatric and Adolescent Gynecology|February 13, 2017
Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescentsAndreas D Ebert, Liying Dong, Martin Merz, et al.
Transplantation|April 23, 2009
Cold ischemia does not interfere with tolerance inductionAnja Reutzel-Selke, Jan Hartmann, Paul Brandenburg, et al.
Menopause (New York, N.Y.)|September 2, 2025
Treatment patterns in women with breast cancer and endocrine therapy-related menopausal symptoms: a cohort study from the United States, United Kingdom, and GermanyMariam Saadedine, Victoria Banks, Carina Dinkel-Keuthage, et al.
Climacteric : the Journal of the International Menopause Society|July 30, 2025
Treatments in women experiencing natural menopause: a cohort study from the USA, the UK and GermanyMariam Saadedine, Victoria Banks, Carina Dinkel-Keuthage, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 29, 2008
Donor brain death significantly interferes with tolerance induction protocolsMaja Francuski, Anja Reutzel-Selke, Sascha Weiss, et al.
The New England Journal of Medicine|June 2, 2025
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast CancerFatima Cardoso, Susanne Parke, Donal J Brennan, et al.
JAMA Internal Medicine|September 8, 2025
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical TrialNick Panay, Hadine Joffe, Pauline M Maki, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Patient-Reported Outcomes|July 1, 2025
Qualitative exploration of women's experiences of vasomotor symptoms to support the content validity of patient-reported outcomesClaudia Haberland, Melissa Barclay, Sophie Whyman, et al.
Journal of Pediatric and Adolescent Gynecology|February 13, 2017
Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescentsAndreas D Ebert, Liying Dong, Martin Merz, et al.
Transplantation|April 23, 2009
Cold ischemia does not interfere with tolerance inductionAnja Reutzel-Selke, Jan Hartmann, Paul Brandenburg, et al.
Menopause (New York, N.Y.)|September 2, 2025
Treatment patterns in women with breast cancer and endocrine therapy-related menopausal symptoms: a cohort study from the United States, United Kingdom, and GermanyMariam Saadedine, Victoria Banks, Carina Dinkel-Keuthage, et al.
Climacteric : the Journal of the International Menopause Society|July 30, 2025
Treatments in women experiencing natural menopause: a cohort study from the USA, the UK and GermanyMariam Saadedine, Victoria Banks, Carina Dinkel-Keuthage, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 29, 2008
Donor brain death significantly interferes with tolerance induction protocolsMaja Francuski, Anja Reutzel-Selke, Sascha Weiss, et al.
The New England Journal of Medicine|June 2, 2025
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast CancerFatima Cardoso, Susanne Parke, Donal J Brennan, et al.
JAMA Internal Medicine|September 8, 2025
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical TrialNick Panay, Hadine Joffe, Pauline M Maki, et al.
Pageof 1